MAP kinase signalling pathways in cancer AS Dhillon, S Hagan, O Rath, W Kolch Oncogene 26 (22), 3279-3290, 2007 | 3658 | 2007 |
Tear fluid biomarkers in ocular and systemic disease: potential use for predictive, preventive and personalised medicine. ESA Hagan S, Martin E EPMA J 7, 15, 2016 | 343* | 2016 |
Reduction of Raf-1 kinase inhibitor protein expression correlates with breast cancer metastasis S Hagan, F Al-Mulla, E Mallon, K Oien, R Ferrier, B Gusterson, ... Clinical Cancer Research 11 (20), 7392-7397, 2005 | 342 | 2005 |
Reduction in Raf kinase inhibitor protein expression is associated with increased Ras-extracellular signal-regulated kinase signaling in melanoma cell lines MM Schuierer, F Bataille, S Hagan, W Kolch, AK Bosserhoff Cancer research 64 (15), 5186-5192, 2004 | 260 | 2004 |
Absence of xenotropic murine leukaemia virus-related virus in UK patients with chronic fatigue syndrome HCT Groom, VC Boucherit, K Makinson, E Randal, S Baptista, S Hagan, ... Retrovirology 7, 1-10, 2010 | 247 | 2010 |
Raf kinase inhibitor protein expression in a survival analysis of colorectal cancer patients F Al-Mulla, S Hagan, AI Behbehani, MS Bitar, SS George, JJ Going, ... Journal of Clinical Oncology 24 (36), 5672-5679, 2006 | 215 | 2006 |
Hepatocyte growth factor/scatter factor in the eye I Grierson, L Heathcote, P Hiscott, P Hogg, M Briggs, S Hagan Progress in retinal and eye research 19 (6), 779-802, 2000 | 164 | 2000 |
EPMA position paper in cancer: current overview and future perspectives G Grech, X Zhan, BC Yoo, R Bubnov, S Hagan, R Danesi, G Vittadini, ... EPMA Journal 6, 1-31, 2015 | 116 | 2015 |
Raf kinase inhibitor protein: mechanism of loss of expression and association with genomic instability F Al-Mulla, S Hagan, W Al-Ali, SP Jacob, AI Behbehani, MS Bitar, A Dallol, ... Journal of clinical pathology 61 (4), 524-529, 2008 | 105 | 2008 |
Pathobiology of epiretinal and subretinal membranes: possible roles for the matricellular proteins thrombospondin 1 and osteonectin (SPARC) P Hiscott, S Hagan, L Heathcote, CM Sheridan, CP Groenewald, ... Eye 16 (4), 393-403, 2002 | 102 | 2002 |
Targeted therapies in colorectal cancer—an integrative view by PPPM S Hagan, MCM Orr, B Doyle EPMA Journal 4, 1-16, 2013 | 86 | 2013 |
A gene signature for post-infectious chronic fatigue syndrome JW Gow, S Hagan, P Herzyk, C Cannon, PO Behan, A Chaudhuri BMC medical genomics 2, 1-11, 2009 | 85 | 2009 |
Loss of heterozygosity on chromosomes 3, 9, 13, and 17, including the retinoblastoma locus, in uveal melanoma AGM Scholes, T Liloglou, P Maloney, S Hagan, J Nunn, P Hiscott, ... Investigative ophthalmology & visual science 42 (11), 2472-2477, 2001 | 65 | 2001 |
Tear fluid biomarker profiling: a review of multiplex bead analysis S Hagan, A Tomlinson The ocular surface 11 (4), 219-235, 2013 | 63 | 2013 |
Raf kinase inhibitor protein regulation of raf and MAPK signaling S Hagan, R Garcia, A Dhillon, W Kolch Methods in enzymology 407, 248-259, 2006 | 58 | 2006 |
Cultured human retinal pigment epithelial cells differentially express thrombospondin-1,-2,-3, and-4 JA Carron, P Hiscott, S Hagan, CM Sheridan, R Magee, JA Gallagher The international journal of biochemistry & cell biology 32 (11-12), 1137-1142, 2000 | 46 | 2000 |
Patient-reported severity of dry eye and quality of life in diabetes MK Yazdani-ibn-Taz, MM Han, S Jonuscheit, A Collier, JE Nally, S Hagan Clinical Ophthalmology (Auckland, NZ) 13, 217, 2019 | 43 | 2019 |
Biomarkers of ocular surface disease using impression cytology S Hagan Biomarkers in medicine 11 (12), 1135-1147, 2017 | 42 | 2017 |
Overexpression of epidermal growth factor receptor restricted to macrophages in uveal melanoma AGM Scholes, S Hagan, P Hiscott, BE Damato, I Grierson Archives of ophthalmology 119 (3), 373-377, 2001 | 39 | 2001 |
Mutationally activated K-ras 4A and 4B both mediate lung carcinogenesis CE Patek, MJ Arends, WAH Wallace, F Luo, S Hagan, DG Brownstein, ... Experimental cell research 314 (5), 1105-1114, 2008 | 36 | 2008 |